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1. Introduction 
Cell motility and locomotion are important for many cellular functions. The cell skeleton or cytoskeleton remodels itself 
during multiple cellular tasks. For example, the actin cortical cytoskeleton undergoes significant changes during 
endocytosis, cell migration, adhesion and bacterial invasion [1]. 
 The cytoskeleton is made up of actin, intermediate and tubulin filaments. There is crosstalk among these constituents, 
allowing then to behave as a complex network. We are just beginning to understand some of the aspects of this network 
and to flesh out the broad strokes of how it is regulated. We are confronted by great biological complexity, so we must 
try to simplify it in order to understand it. Thus, it would contribute to our knowledge of the cytoskeleton as a whole if 
we focus on some details of a particular protein that helps to orchestrate some of these changes. This review focuses on 
cortactin, a protein that has emerged as an important convergence node in the regulation of the cytoskeleton during 
numerous biological tasks. More than to give an exhaustive review, our intention is to give a general vision of the best 
known aspects of this protein, while highlighting with a personal view some more controversial aspects that may 
require further studies. We recommend some recent reviews of cortactin that complement the present one [2,3]. 
2. From the first studies of cortactin to the present 
Cortactin was originally described as a protein located at the cell cortex and as a substrate of the Src kinase [4]. At 
nearly the same time, it was identified as the product of the CTTN gene (formerly EMS1), located in a chromosomal 
region, 11q13, frequently amplified in different human carcinomas [5]. Today, cortactin is considered an oncoprotein 
and a bona fide invadopodia marker. Invadopodia are actin-rich protrusions of the cell membrane that penetrate the 
extracellular matrix and degrade it, mainly through the accumulation and action of metalloproteinases [6,7]. At the same 
time, cortactin is a preferential target for bacterial and viral pathogens that subvert the cytoskeleton to their own benefit. 
For this reason, it has been called ‘the Achilles’ heel of the actin cytoskeleton’ [8]. 
3. Cortactin is an important node in the regulation of the actin cellular network 
Cortactin is a modular protein that participates in many signals that converge on the alteration of the actin cytoskeleton. 
Actin polymerization occurs when the globular monomeric form (G-actin) ensembles into a filamentous form (F-actin). 
The initial formation of a dimeric or a trimeric nucleus is unstable, and it is promoted and controlled by proteins that 
facilitate the process. One such protein is the Arp2/3 complex, which comprises two subunits, called actin-related 
proteins 2 and 3, as well as five other subunits. This complex is able to add a ‘branch’ to the side of a preexisting 
filament, giving rise to branched filaments with a characteristic 70-degree angle [1]. 
 Cortactin has an N-terminal acidic motif (NTA) that directly binds and activates the Arp2/3 complex, thereby 
behaving as a nucleation-promoting factor (NPF). The NTA domain is followed by a six and a half repeats of amino 
acids that bind to F-actin, binding that is required for cortactin activity [3]. However cortactin is a weak activator of the 
Arp2/3 complex in vitro, which raises the question of whether wild-type (WT) cortactin is active or whether it requires 
some post-translational modification to be fully active. Indeed, although cortactin has a predicted molecular weight of 
approximately 65 kDa, it migrates as an 80/85 kDa doublet in SDS-PAGE. To add to the complexity, cortactin is 
expressed as several isoforms that differ in the number of repeats, which seems to be related to the location of these 
isoforms to cell-cell contacts in epithelial cells [9]. In particular, a detailed analysis of cortactin expression is needed for 
immunological cells, since in most situations it is assumed that a paralog protein HS1 plays the role of cortactin. We 
favor the hypothesis that the pattern of expression of cortactin is similar to that of N-WASP/WASP (see next 
paragraph). Clearly, we do not understand some basic aspects of cortactin expression and post-translational 
modification. 
 There is another way in which cortactin can promote actin nucleation: its SH3 terminal domain binds directly and 
activates the neural Wiskott-Aldrich syndrome protein (N-WASP) [10, 11]. The first described activators of the Arp2/3 
complex were the WASP family of proteins. The representative member of the family, WASP, which is expressed 
exclusively in the immune system, is mutated in the immune deficiency called Wiskott-Aldrich syndrome (WAS). N-
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Abstract
Background: Cortactin is a classical Src kinase substrate that participates in actin cytoskeletal dynamics by activating the
Arp2/3 complex and interacting with other regulatory proteins, including FAK. Cortactin has various domains that may
contribute to the assembly of different protein platforms to achieve process specificity. Though the protein is known to be
regulated by post-translational modifications such as phosphorylation and acetylation, how tyrosine phosphorylation
regulates cortactin activity is poorly understood. Since the basal level of tyrosine phosphorylation is low, this question must
be studied using stimulated cell cultures, which are physiologically relevant but unreliable and difficult to work with. In fact,
their unreliability may be the cause of some contradictory findings about the dynamics of tyrosine phosphorylation of
cortactin in different processes.
Methodology/Principal Findings: In the present study, we try to overcome these problems by using a Functional
Interaction Trap (FIT) system, which involves cotransfecting cells with a kinase (Src) and a target protein (cortactin), both of
which are fused to complementary leucine-zipper domains. The FIT system allowed us to control precisely the tyrosine
phosphorylation of cortactin and explore its relationship with cortactin acetylation.
Conclusions/Significance: Using this system, we provide definitive evidence that a competition exists between acetylation
and tyrosine phosphorylation of cortactin and that phosphorylation inhibits cell spreading. We confirmed the results from
the FIT system by examining endogenous cortactin in different cell types. Furthermore, we demonstrate that cell spreading
promotes the association of cortactin and FAK and that tyrosine phosphorylation of cortactin disrupts this interaction,
which may explain how it inhibits cell spreading.
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Introduction
The actin cytoskeleton remodels to accomplish many cellular
processes and therefore undergoes significant changes during cell
migration, adhesion, endocytosis and bacterial invasion [1]. The
cortactin protein has emerged as an important node in the
network regulating the actin cytoskeleton during numerous
biological processes [2,3]. It was originally described as a substrate
of Src kinase located primarily at the cell cortex [4]. Almost
simultaneously, cortactin was cloned as the product of the CTTN
gene (formerly EMS1), located in chromosomal region 11q13,
which is frequently amplified in different human carcinomas [5].
Today, cortactin is considered an oncoprotein and a bona fide
invadopodial marker [6].
Cortactin is a modular protein that contains an N-terminal
acidic (NTA) domain with a 20DDW22 motif that directly binds
and activates the Arp2/3 complex. The NTA domain is followed
by six and a half amino acid ‘repeats’ that bind to F-actin and
define the actin-binding region (ABR) [7]. Since cortactin only
weakly activates the Arp2/3 complex in vitro [8], it is unclear
whether cortactin requires post-translational modifications to be
fully active. The ABR is followed by a helical, proline-rich region,
followed in turn by a C-terminal Src homology (SH3) domain.
Cortactin binds several proteins through its SH3 domain, such as
WIP [9] and neural Wiskott-Aldrich syndrome protein (N-WASP)
[10,11].
Cortactin regulation is very complex [12]. Although tradition-
ally studied as a substrate of Src family kinases (SFKs) [4], it can
also be phosphorylated by other tyrosine kinases such as Fer [13]
and Abl/Arg [14]. The effects of tyrosine phosphorylation on
cortactin structure and function remain largely unknown. This
phosphorylation was shown to decrease cortactin binding to F-
actin [15], and this binding is required for cortactin activation of
the Arp2/3 complex [16]. This phosphorylation is also required
for inducing bone metastasis of breast cancer cells in nude mice
[17], and it appears to be involved in bacterial invasion of cells,
such as for the adhesion of enteropathogenic Escherichia coli (EPEC)
[18]. Protein phosphatase 1B (PTB-1B) dephosphorylates tyrosine
421 in cortactin [19], suggesting reversible regulation. The data
seem to indicate that tyrosine phosphorylation of cortactin is
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Abstract
Infections by enteropathogenic Escherichia coli (EPEC) cause diarrhea linked to high infant mortality in developing countries.
EPEC adheres to epithelial cells and induces the formation of actin pedestals. Actin polymerization is driven fundamentally
through signaling mediated by Tir bacterial effector protein, which inserts in the plasma membrane of the infected cell. Tir
binds Nck adaptor proteins, which in turn recruit and activate N-WASP, a ubiquitous member of the Wiskott-Aldrich
syndrome family of proteins. N-WASP activates the Arp2/3 complex to promote actin polymerization. Other proteins aside
from components of the Tir-Nck-N-WASP pathway are recruited to the pedestals but their functions are unknown. Here we
investigate the function of two alternatively spliced isoforms of Crk adaptors (CrkI/II) and the paralog protein CrkL during
pedestal formation by EPEC. We found that the Crk isoforms act as redundant inhibitors of pedestal formation. The SH2
domain of CrkII and CrkL binds to phosphorylated tyrosine 474 of Tir and competes with Nck to bind Tir, preventing its
recruitment to pedestals and thereby inhibiting actin polymerization. EPEC infection induces phosphorylation of the major
regulatory tyrosine in CrkII and CrkL, possibly preventing the SH2 domain of these proteins from interacting with Tir.
Phosphorylated CrkII and CrkL proteins localize specifically to the plasma membrane in contact with EPEC. Our study
uncovers a novel role for Crk adaptors at pedestals, opening a new perspective in how these oncoproteins regulate actin
polymerization.
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Introduction
Enteropathogenic Escherichia coli (EPEC) causes infant diarrhea
worldwide and is a leading cause of death in developing countries.
EPEC adheres to intestinal epithelial cells, causing local
disappearance of microvilli and altering cell permeability, giving
rise to what are classically known as attaching and effacing (A/E)
lesions [1]. At A/E lesions, EPEC attaches to host cells and
induces the formation of actin-rich structures called pedestals.
Although the ultimate function of pedestals is not completely
understood, disrupting genes critical for pedestal formation
diminishes colonization and subsequent disease in humans [2]
and animal models [3]. Pedestals may facilitate EPEC growth and
residence inside the intestine by allowing the bacteria to remain
attached to the epithelium during peristalsis and host responses to
infection [4].
EPEC uses a type III secretion system to deliver effectors into
host cells. One such effector is the translocated intimin receptor,
Tir, which drives the major pathway responsible for regulating
actin polymerization. Upon injection into the cell cytoplasm, Tir
inserts in the plasma membrane, exposing a loop on the cell
surface, which in turn binds another bacterial protein, the adhesin
intimin [5]. This binding is accompanied by the clustering of Tir
and by its phosphorylation on Tyr474 within the C-terminal
cytoplasmic domain. This regulatory phosphotyrosine recruits the
host cell adaptor protein non-catalytic tyrosine kinase Nck, which
in turn recruits N-WASP [6]. Recruitment and activation of N-
WASP [7] and of other actin-nucleating proteins such as cortactin
[8,9] leads to Arp2/3 complex-mediated actin polymerization.
Pedestals act as a ‘‘molecular niche’’ to recruit not only actin
machinery but many other proteins as well. These proteins include
those normally localized to focal adhesions, such as vinculin and
talin [10], cell cortex proteins such as ezrin [11] and adaptor
proteins such as CT10 regulator of kinase (Crk) proteins [12].
Several excellent reviews have recently been written about EPEC
signaling [13,14,15].
The first member of the Crk adaptor family to be discovered
was v-Crk, a chicken tumor viral oncoprotein that increases
tyrosine phosphorylation in cells [16]. The cellular counterpart of
v-Crk is CrkII, a proto-oncoprotein that contains an N-terminal
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